140 Relationship between programmed death ligand 1 (PD-L1) expression and clinical outcome in patients (pts) with melanoma (MEL) treated with pembrolizumab (pembro; MK-3475)Adil Daud, A. Ribas, Hassane M. Zarour et al.|European Journal of Cancer|2014Cited by 6